Status:
COMPLETED
A Self-efficAcy Intervention to reDuce Injecting Risk behAviour and hePatitis c reinfecTion Rates
Lead Sponsor:
University of Dundee
Collaborating Sponsors:
NHS Tayside
Conditions:
Hepatitis C
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study evaluates the use of implementation intentions to increase self-efficacy and reduce injecting risk behaviour in a sample of injecting drug users on treatment for hepatitis C (HCV). The overa...
Detailed Description
The intervention will entail completing a volitional help sheet.This will create implementation intentions, which are self-regulatory strategies taking the form of "if-then" plans (i.e. situation-solu...
Eligibility Criteria
Inclusion
- Male or Female. (Over 18 years of age);
- Chronic HCV positive infection;
- Current illicit drug use established through participants' self-report;
- Current HCV treatment provided by the NHS;
- Informed consent, agreeing to study and monitoring criteria;
- English-speaking.
Exclusion
- Inability to provide informed consent;
- Aggressive or violent behaviour;
- Not currently receiving HCV treatment;
- Inability to communicate in English.
Key Trial Info
Start Date :
February 22 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 3 2020
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT03293576
Start Date
February 22 2018
End Date
January 3 2020
Last Update
August 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairn Centre Needle Exchange
Dundee, United Kingdom, DD1 4NA